AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $7.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $4.89M, a 201.36% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $2.46M, a 15.63% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $945.00K, a 0.32% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.52M, a 128.40% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $3.17M, a 45.41% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $5.81M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$3.83M, a 2277.84% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $176.00K, a 99.34% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $7.34M 10-Q · filed 2026-07-30 | $8.29M derived: sum of 3 quarters · filed 2026-07-30 | $6.77M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.46M 10-Q · filed 2026-04-29 | $3.40M derived: sum of 2 quarters · filed 2026-04-29 | $1.88M derived: sum of 3 quarters · filed 2026-04-29 | $3.50M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$574.00K derived: sum of 2 quarters · filed 2026-02-12 | $1.05M derived: sum of 3 quarters · filed 2026-07-30 | $3.17M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $103.00K derived: sum of 2 quarters · filed 2026-07-30 | $2.23M 10-Q · filed 2025-10-30 | $3.17M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.75M 10-Q · filed 2026-07-30 | $4.69M derived: sum of 3 quarters · filed 2026-07-30 | $10.04M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $2.12M 10-Q · filed 2026-04-29 | $3.07M derived: sum of 2 quarters · filed 2026-04-29 | $8.42M derived: sum of 3 quarters · filed 2026-04-29 | $3.84M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $948.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $6.30M derived: sum of 2 quarters · filed 2026-02-12 | $1.72M derived: sum of 3 quarters · filed 2026-02-12 | $5.81M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $5.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $772.00K derived: sum of 2 quarters · filed 2025-10-30 | $4.86M 10-Q · filed 2025-10-30 | $1.47M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | -$4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$486.00K 10-Q · filed 2025-07-31 | -$3.88M derived: sum of 3 quarters · filed 2026-02-12 | -$2.22M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $4.09M 10-Q · filed 2025-05-01 | $698.00K derived: sum of 2 quarters · filed 2026-02-12 | $2.36M derived: sum of 3 quarters · filed 2026-02-12 | -$90.00K derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$1.73M derived: sum of 2 quarters · filed 2026-02-12 | -$4.18M derived: sum of 3 quarters · filed 2026-02-12 | -$3.83M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$788.00K derived: sum of 2 quarters · filed 2024-10-31 | -$440.00K 10-Q · filed 2024-10-31 | -$7.92M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$2.10M 10-Q · filed 2024-08-01 | -$9.58M derived: sum of 3 quarters · filed 2025-02-13 | -$5.48M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $348.00K 10-Q · filed 2024-05-02 | -$7.13M derived: sum of 2 quarters · filed 2025-02-13 | -$3.03M derived: sum of 3 quarters · filed 2025-02-13 | -$2.87M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | -$7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$3.38M derived: sum of 2 quarters · filed 2025-02-13 | -$3.21M derived: sum of 3 quarters · filed 2025-02-13 | $176.00K 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.26M derived: sum of 2 quarters · filed 2023-11-02 | $7.66M 10-Q · filed 2023-11-02 | $15.25M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.56M 10-Q · filed 2023-08-03 | $11.15M derived: sum of 3 quarters · filed 2024-02-15 | $21.95M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $3.39M 10-Q · filed 2023-05-04 | $10.99M derived: sum of 2 quarters · filed 2024-02-15 | $21.78M derived: sum of 3 quarters · filed 2024-02-15 | $26.62M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $18.39M derived: sum of 2 quarters · filed 2024-02-15 | $23.23M derived: sum of 3 quarters · filed 2024-02-15 | $26.85M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $10.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.63M derived: sum of 2 quarters · filed 2022-11-03 | $19.25M 10-Q · filed 2022-11-03 | $18.02M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $8.45M 10-Q · filed 2022-08-04 | $7.23M derived: sum of 3 quarters · filed 2023-02-23 | $9.75M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $3.62M 10-Q · filed 2022-05-05 | $2.39M derived: sum of 2 quarters · filed 2023-02-23 | $4.92M derived: sum of 3 quarters · filed 2023-02-23 | $2.55M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.30M derived: sum of 2 quarters · filed 2023-02-23 | -$1.07M derived: sum of 3 quarters · filed 2023-02-23 | $3.00K 10-K · filed 2023-02-23 | $599.00K 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $155.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.23M 10-Q · filed 2021-11-03 | $6.03M 10-Q · filed 2020-11-05 | $1.43M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$1.29M 10-Q · filed 2021-07-29 | $4.36M 10-Q · filed 2020-07-30 | -$1.10M derived: sum of 3 quarters · filed 2022-02-24 | -$61.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $1.08M 10-Q · filed 2021-04-29 | $6.77M 10-Q · filed 2020-04-30 | $1.27M derived: sum of 2 quarters · filed 2022-02-24 | $2.31M derived: sum of 3 quarters · filed 2022-02-24 | $2.65M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.23M derived: sum of 2 quarters · filed 2022-02-24 | $1.58M derived: sum of 3 quarters · filed 2022-02-24 | $3.75M 10-K · filed 2022-02-24 | $7.74M 10-K · filed 2020-02-19 | |||
| 2019-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.38M derived: sum of 2 quarters · filed 2020-11-05 | $3.55M 10-Q · filed 2020-11-05 | $4.12M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.52M 10-Q · filed 2020-07-30 | $3.08M derived: sum of 3 quarters · filed 2021-02-25 | $3.78M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.17M 10-Q · filed 2020-04-30 | $2.74M derived: sum of 2 quarters · filed 2021-02-25 | $3.44M derived: sum of 3 quarters · filed 2021-02-25 | $2.93M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.26M derived: sum of 2 quarters · filed 2021-02-25 | $753.00K derived: sum of 3 quarters · filed 2021-02-25 | -$1.15M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $190.00K derived: sum of 2 quarters · filed 2019-10-31 | -$1.71M 10-Q · filed 2019-10-31 | $3.00K derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$2.41M 10-Q · filed 2019-08-01 | -$699.00K derived: sum of 3 quarters · filed 2020-02-19 | -$1.23M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$1.90M 10-Q · filed 2019-05-02 | -$187.00K derived: sum of 2 quarters · filed 2020-02-19 | -$718.00K derived: sum of 3 quarters · filed 2020-02-19 | -$1.73M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.18M derived: sum of 2 quarters · filed 2020-02-19 | $175.00K derived: sum of 3 quarters · filed 2020-02-19 | $3.60M 10-K · filed 2020-02-19 | $6.53M 10-K · filed 2018-02-14 | |||
| 2017-09-30 | -$531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$1.54M derived: sum of 2 quarters · filed 2018-11-01 | $1.89M 10-Q · filed 2018-11-01 | $4.44M 10-Q · filed 2017-11-01 | $1.84M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2017-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.42M 10-Q · filed 2018-08-02 | $2.37M derived: sum of 3 quarters · filed 2019-02-14 | $3.71M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | $3.42M 10-Q · filed 2018-05-04 | $3.38M derived: sum of 2 quarters · filed 2019-02-14 | $4.72M derived: sum of 3 quarters · filed 2019-02-14 | $4.99M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.29M derived: sum of 2 quarters · filed 2019-02-14 | $1.56M derived: sum of 3 quarters · filed 2019-02-14 | $2.42M 10-K · filed 2019-02-14 | $2.69M 10-K · filed 2017-02-16 | |||
| 2016-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.61M derived: sum of 2 quarters · filed 2017-11-01 | $2.46M 10-Q · filed 2017-11-01 | $3.92M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.13M 10-Q · filed 2017-08-08 | $2.58M derived: sum of 3 quarters · filed 2018-02-14 | $5.02M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | $857.00K 10-Q · filed 2017-05-04 | $2.31M derived: sum of 2 quarters · filed 2018-02-14 | $4.75M derived: sum of 3 quarters · filed 2018-02-14 | $3.92M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $3.89M derived: sum of 2 quarters · filed 2018-02-14 | $3.06M derived: sum of 3 quarters · filed 2018-02-14 | $3.77M 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.61M derived: sum of 2 quarters · filed 2016-11-03 | $2.32M 10-Q · filed 2016-11-03 | $2.44M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | -$833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$125.00K 10-Q · filed 2016-08-08 | -$3.00K derived: sum of 3 quarters · filed 2017-02-16 | $1.96M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $708.00K 10-Q · filed 2016-05-09 | $830.00K derived: sum of 2 quarters · filed 2017-02-16 | $2.79M derived: sum of 3 quarters · filed 2017-02-16 | $2.66M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.09M derived: sum of 2 quarters · filed 2017-02-16 | $1.95M derived: sum of 3 quarters · filed 2017-02-16 | $2.88M 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.83M derived: sum of 2 quarters · filed 2015-11-06 | $2.76M 10-Q · filed 2015-11-06 | $2.63M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $791.00K 10-Q · filed 2015-08-07 | $669.00K derived: sum of 3 quarters · filed 2016-02-26 | -$337.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $930.00K 10-Q · filed 2015-05-11 | $808.00K derived: sum of 2 quarters · filed 2016-02-26 | -$198.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.95M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | -$122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$1.13M derived: sum of 2 quarters · filed 2016-02-26 | $1.02M derived: sum of 3 quarters · filed 2016-02-26 | $1.56M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.14M derived: sum of 2 quarters · filed 2013-11-07 | $1.68M 10-Q · filed 2013-11-07 | $1.32M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-09-05 | $2.69M 10-Q · filed 2013-09-05 | $2.32M derived: sum of 3 quarters · filed 2015-02-24 | $2.86M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $544.00K 10-Q · filed 2014-05-09 | $178.00K derived: sum of 2 quarters · filed 2015-02-24 | $710.00K derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2012-12-31 | -$366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $166.00K derived: sum of 2 quarters · filed 2015-02-24 | $94.00K 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $460.00K 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | -$72.00K 10-Q · filed 2013-09-05 | |||||||
| 2011-12-31 | $63.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |